A phase 4 multicentre, 2×2 factorial randomised, double-blind, placebo-controlled trial to investigate the efficacy and safety of tobramycin inhalation solution for Pseudomonas aeruginosa eradication in bronchiectasis: ERASE.

Gao YH, Lu HW, Zheng HZ, Cao C, Chu DJ, Fan H, Fan XY, Gu HY, Guan WJ, Jie ZJ, Jin Y, Li W, Li YP, Li YY, Liu L, Liu XD, Luo H, Lv XD, Mo WQ, Song YL, Wang DX, Wang LW, Wang CZ, Xie M, Zhang M, Zheng CX, Mao B, Chotirmall SH, Chalmers JD, Qu JM, Xu JF

Open source

DOI: 10.1183/23120541.00938-2023
Published: 2024 Jan
Container: ERJ open research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1183/23120541.00938-2023,
  title = {A phase 4 multicentre, 2×2 factorial randomised, double-blind, placebo-controlled trial to investigate the efficacy and safety of tobramycin inhalation solution for Pseudomonas aeruginosa eradication in bronchiectasis: ERASE.},
  author = {Gao YH and Lu HW and Zheng HZ and Cao C and Chu DJ and Fan H and Fan XY and Gu HY and Guan WJ and Jie ZJ and Jin Y and Li W and Li YP and Li YY and Liu L and Liu XD and Luo H and Lv XD and Mo WQ and Song YL and Wang DX and Wang LW and Wang CZ and Xie M and Zhang M and Zheng CX and Mao B and Chotirmall SH and Chalmers JD and Qu JM and Xu JF},
  year = {2024},
  journal = {ERJ open research},
  doi = {10.1183/23120541.00938-2023},
  url = {https://doi.org/10.1183/23120541.00938-2023}
}

RIS

TY  - JOUR
TI  - A phase 4 multicentre, 2×2 factorial randomised, double-blind, placebo-controlled trial to investigate the efficacy and safety of tobramycin inhalation solution for Pseudomonas aeruginosa eradication in bronchiectasis: ERASE.
AU  - Gao YH
AU  - Lu HW
AU  - Zheng HZ
AU  - Cao C
AU  - Chu DJ
AU  - Fan H
AU  - Fan XY
AU  - Gu HY
AU  - Guan WJ
AU  - Jie ZJ
AU  - Jin Y
AU  - Li W
AU  - Li YP
AU  - Li YY
AU  - Liu L
AU  - Liu XD
AU  - Luo H
AU  - Lv XD
AU  - Mo WQ
AU  - Song YL
AU  - Wang DX
AU  - Wang LW
AU  - Wang CZ
AU  - Xie M
AU  - Zhang M
AU  - Zheng CX
AU  - Mao B
AU  - Chotirmall SH
AU  - Chalmers JD
AU  - Qu JM
AU  - Xu JF
PY  - 2024
JO  - ERJ open research
DO  - 10.1183/23120541.00938-2023
UR  - https://doi.org/10.1183/23120541.00938-2023
ER  -

APA

YH, G., HW, L., HZ, Z., C, C., DJ, C., H, F., XY, F., HY, G., WJ, G., ZJ, J., Y, J., W, L., YP, L., YY, L., L, L., XD, L., H, L., XD, L., WQ, M., YL, S., DX, W., LW, W., CZ, W., M, X., M, Z., CX, Z., B, M., SH, C., JD, C., JM, Q., & JF, X. (2024). A phase 4 multicentre, 2×2 factorial randomised, double-blind, placebo-controlled trial to investigate the efficacy and safety of tobramycin inhalation solution for Pseudomonas aeruginosa eradication in bronchiectasis: ERASE.. ERJ open research. https://doi.org/10.1183/23120541.00938-2023

Source records

pubmed · retrieved 2026-09-25T23:55:25.892Z